The RWD & RWE Podcast

Ep 110 [27 September 2023]: Kirk Geale M.Sc PhD – Finding true north: Navigating the Nordic RWD environment

Ep 110 [27 September 2023]: Conversation with Kirk Geale M.Sc PhD, CEO at Quantify Research – We had an informative discussion on the Nordic real-world data (RWD) landscape and its use cases: small place, high quality big data!

20 September 2023: Matt Veatch MBA and Aaron Kamauu MD MS MPH – RWW: Ask Us Anything!

20 September 2023: Conversation with Matt Veatch MBA and Aaron Kamauu MD MS MPH, Real-World Wednesdays (RWW) co-hosts, senior advisors in RWD, RWE, Decentralized Research; and co-founders of Navidence – We discussed our respective journeys, interests & passions in this field.

13 September 2023: H. Jack West MD MPhil – Clinical Decision Making: Perfect as the Enemy of the Good

13 September 2023: Conversation with H. Jack West MD MPhil, Medical Oncologist & Clinical Associate Professor at City of Hope and VP of Network Strategy at AccessHope – We had a thought-provoking discussion from clinical point-of-care around the real-world use of medical evidence. Though RWD may not be perfect "in the land of the blind, the one-eyed man is king!"Reference: Clinical Decision Making in the Real World—The Perfect as the Enemy of the Good: https://jamanetwork.com/journals/jamaoncology/fullarticle/2805799

26 July 2023: Joris Van Dam – (Untapped) RWD opportunity in developing diagnostic devices

26 July 2023: Conversation with Joris Van Dam, Digital Health Intrapreneur, VP Digital Strategy at Exact Sciences and former Executive Director, Head of Digital Therapeutics at Novartis/NIBR – We discussed the pressing opportunity & need for RWD in diagnostic device development from both a pharma and medical device perspective.

19 July 2023: Andrew Ecob MBA – Emerging Tech - effect on People & Process in RWE studies

19 July 2023: Conversation with Andrew Ecob MBA, advisor and consultant in the RWD/RWE arena, former Head of Emerging Design Delivery, Innovation and Data Strategy - Real World Solutions at IQVIA and former VP of RWE Strategy at Parexel – We discussed how organisations manage innovation that is radical or sustaining, and how will this affect delivery models for generating RWE.

12 July 2023: Mike LaChance – Imaging RWE - A commercial perspective

12 July 2023: Conversation with Mike LaChance, former CEO of OneMedNet and Co-Chair AI/ML Industry Liaison Sub-Committee, Society for Imaging Informatics in Medicine (SIIM) – We had an interactive conversation about imaging RWD and RWE.

28 June 2023: Dan O’Connor – Real World Data in the Real World Capital Market

28 June 2023: Conversation with Dan O'Connor, Managing Partner at Contour Ridge – We had an interactive conversation on the RWD/RWE market, trends, and future.

21 June 2023: Aaron Leibtag – Unstructured RWD: The search for patients using AI

21 June 2023: Conversation with AI entrepreneur, Aaron Leibtag, CEO of Pentavere.ai – We discussed AI based approaches to clinical care and research patient selection, including a great foundation on what NLP is and how it is evolving.

14 June 2023: Tom Dougherty MBA – Navigating a crowded and convoluted RWD market space

14 June 2023: Conversation with Tom Dougherty MBA, Director of RWE Partnerships & Innovation at Pfizer – We discussed challenges navigating the RWD market space and characteristics of the ideal RWD partner; as well as driving innovation within a large life sciences company.

07 June 2023: Keith Kallmes & Kevin Kallmes JD MA – Using AI for unified Health Technology Assessments (HTAs)

07 June 2023: Conversation with serial entrepreneurs Keith & Kevin Kallmes (Nested Knowledge, Marblehead Medical, Superior Medical Experts) – We discussed a non-technical, exploratory conversation about the use of AI to establish a unified protocol supporting evidence synthesis in global Health Technology Assessment (HTA) regulatory submissions.

References during the discussion:
- https://www.eunethta.eu/
- https://about.nested-knowledge.com/2023/01/18/can-chatgpt-do-your-next-systematic-review/
- https://www.linkedin.com/posts/nested-knowledge_how-is-nested-knowledge-deploying-ai-today-activity-7055245807561687040-TglG

From the live chat:
[00:21] Madhusudan Kabra: SLR - clinical, economic, utility values etc. in a embase etc.
[00:22] Stu McCully: The requirements of EUnetHTA will be replaced by the EU Health Technology Assessment Regulation in May 2025
[00:22] David Thompson: And it's pronounced yoo-NET-uh
[00:29] Stu McCully: ChatGPT - totally agreement with Kevin’s concerns about its limitations
[00:40] Charlie Barr: Would add “priorities” and “silos” to “urgency” as reasons why the ideal global dossier isn’t always created at the beginning of HTA preparation process
[00:42] Madhusudan Kabra: There are auto- SLR options available - DistllerSR etc. what you are saying Kevin is the next level in this evolution as to what does it make me understand from this data? Is this correct?